Telix Pharmaceuticals (TLX) Sued After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman

Accessibility StatementSkip Navigation Telix Pharmaceuticals Limited (TLX) Securities Class Action The complaint, captioned Thomas v. Telix Pharmaceuticals Ltd., seeks to represent investors who acquired the company's securities between February 21, 2025, and August 28, 2025 (the "Class Period"). The lawsuit alleges that the company and certain top executives made false and misleading statements about critical aspects of its business, inflating the company's valuation before the truth emerged. .The Core All ...